These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 466535)
1. [Ministat: a new oral contraceptive of the combined type with low estrogen contents]. Demol R; Fondu F; Thiery M; Van Kets H Brux Med; 1979 Apr; 59(4):225-32. PubMed ID: 466535 [No Abstract] [Full Text] [Related]
2. Oral contraceptives according to the normophasic principle. Borglin NE; Klottrup P Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954 [TBL] [Abstract][Full Text] [Related]
3. [Restovar, a new combined oral contraceptive with a low estrogen content]. Fondu F; Lowijck J Brux Med; 1974 Aug; 54(8):453-8. PubMed ID: 4425958 [No Abstract] [Full Text] [Related]
4. [Clinical trial of a combined oral contraceptive with low estrogen dose (author's transl)]. Schmidt-Elmendorff HW MMW Munch Med Wochenschr; 1975 Feb; 117(9):345-8. PubMed ID: 804642 [TBL] [Abstract][Full Text] [Related]
5. [Clinical aspects of a new, very low dose combination contraceptive]. Mladenović D; Grcić R; Pestelek B; Kapor M Fortschr Med; 1978 Apr; 96(13):723-6. PubMed ID: 631715 [TBL] [Abstract][Full Text] [Related]
7. [Effects, on the endometrium, of a new oral contraceptive: Physiostat]. Delacroix P Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717 [No Abstract] [Full Text] [Related]
8. Comparative clinical trial of two oral contraceptives with a low--estrogen content. Koetsawang S; Srisupandit S; Srivannaboon S; Bhiráleus P J Med Assoc Thai; 1977 Aug; 60(8):368-73. PubMed ID: 908899 [No Abstract] [Full Text] [Related]
9. Three and one-half years' experience with a lower-dose combination oral contraceptive. Woutersz TB J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360 [TBL] [Abstract][Full Text] [Related]
11. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg. Christie T J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701 [No Abstract] [Full Text] [Related]
12. [Ovostat 22, a new oral contraceptive]. Himmelsbach H Med Welt; 1974 Jan; 25(3):106-8. PubMed ID: 4840796 [No Abstract] [Full Text] [Related]
13. [Prevention of unwanted pregnancy with Yermonil preparation]. Sternadel Z; Peksa A Ginekol Pol; 1978 Feb; 49(2):139-42. PubMed ID: 565732 [No Abstract] [Full Text] [Related]
14. Less estrogen in new oral contraceptive. Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126 [No Abstract] [Full Text] [Related]
15. Oestrogen content of oral contraceptives and thromboembolism. McQueen EG N Z Med J; 1970 May; 71(456):317. PubMed ID: 5270982 [No Abstract] [Full Text] [Related]
16. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies. Woutersz TB J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254 [TBL] [Abstract][Full Text] [Related]
17. [Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases]. Spasojević M Med Arh; 1984; 38(2):83-4. PubMed ID: 6444082 [No Abstract] [Full Text] [Related]
18. [The search for new ways with low dose contraceptives. II]. Tóth F; Gimes R; Horn B; Kerényi T Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027 [No Abstract] [Full Text] [Related]
19. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
20. Rationale for new oral contraceptive dosing. Williams JK Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]